Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acer Therapeutics Inc (NASDAQ:ACER)

17.81
Delayed Data
As of Oct 20
 +0.0034 / +0.02%
Today’s Change
5.18
Today|||52-Week Range
37.75
+86.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.3M1.3M2.6M2.9M
 
 
 
 
 
Depreciation And Amortization335.6K387.8K351.4K238.1K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.8M16.0M14.3M9.6M
 
 
 
 
 
Research And Development9.2M12.1M10.0M6.5M
 
 
 
 
 
Total Operating Expenses13.2M16.3M14.6M9.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.9M-15.1M-12.1M-7.0M
 
 
 
 
 
Extraordinary Charge-2.5M0.000.00-1.0M
 
 
 
Interest Expense On Debt2.3M2.0K2.3K3.3K
 
 
 
 
 
Other Expenses35.7K2.1K67.5K8.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.7M-15.1M-12.0M-8.0M
 
 
 
 
 
Net Income-16.7M-15.1M-12.0M-8.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS160.9K335.8K565.3K680.7K
 
 
 
 
 
Shares To Calculate EPS Diluted160.9K335.8K565.3K680.7K
 
 
 
 
 
 
Earnings Per ShareEPS-$103.56-$44.74-$21.23-$11.70
 
 
 
 
 
EPS Diluted-$103.56-$44.74-$21.23-$11.70